These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 10484617

  • 1. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
    Vélez-Carrasco W, Lichtenstein AH, Barrett PH, Sun Z, Dolnikowski GG, Welty FK, Schaefer EJ.
    J Lipid Res; 1999 Sep; 40(9):1695-700. PubMed ID: 10484617
    [Abstract] [Full Text] [Related]

  • 2. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [Abstract] [Full Text] [Related]

  • 3. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [Abstract] [Full Text] [Related]

  • 4. Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins.
    Chétiveaux M, Croyal M, Ouguerram K, Fall F, Flet L, Zair Y, Nobecourt E, Krempf M.
    Sci Rep; 2020 Sep 24; 10(1):15585. PubMed ID: 32973209
    [Abstract] [Full Text] [Related]

  • 5. Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
    Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2008 Sep 24; 28(9):1672-8. PubMed ID: 18566298
    [Abstract] [Full Text] [Related]

  • 6. Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.
    Lichtenstein AH, Hachey DL, Millar JS, Jenner JL, Booth L, Ordovas J, Schaefer EJ.
    J Lipid Res; 1992 Jun 24; 33(6):907-14. PubMed ID: 1512514
    [Abstract] [Full Text] [Related]

  • 7. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 1999 Dec 24; 19(12):2966-74. PubMed ID: 10591677
    [Abstract] [Full Text] [Related]

  • 8. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.
    Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ.
    J Lipid Res; 1988 Jul 24; 29(7):925-36. PubMed ID: 3411251
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lipoprotein metabolism in subjects with hepatic lipase deficiency.
    Tilly-Kiesi M, Schaefer EJ, Knudsen P, Welty FK, Dolnikowski GG, Taskinen MR, Lichtenstein AH.
    Metabolism; 2004 Apr 24; 53(4):520-5. PubMed ID: 15045702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF.
    J Clin Endocrinol Metab; 2009 Mar 24; 94(3):989-97. PubMed ID: 19116237
    [Abstract] [Full Text] [Related]

  • 15. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
    Pietzsch J, Julius U, Nitzsche S, Hanefeld M.
    Diabetes; 1998 Dec 24; 47(12):1928-34. PubMed ID: 9836526
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.
    Kido T, Kondo K, Kurata H, Fujiwara Y, Urata T, Itakura H, Yokoyama S.
    Lipids Health Dis; 2017 Nov 29; 16(1):225. PubMed ID: 29187200
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.